申请人:Horiguchi Yoshiaki
公开号:US20080064715A1
公开(公告)日:2008-03-13
A compound represented by the formula
wherein R
1
, R
2
, R
3
and R
6
are the same or different and each is a hydrogen atom or a substituent; one of R
4
and R
5
is a hydrogen atom and the other is a group represented by the formula: —C(═X)—R
7
wherein X is N—O—R
8
or N—NH—R
9
wherein R
8
and R
9
are the same or different and each is a hydrogen atom or a group bonded via a carbon atom; and R
7
is a hydrogen atom or a substituent, and the like and a salt thereof have a superior IκB kinase inhibitory activity, and useful as pharmaceutical agents such as agents for preventing or treating diabetes and the like.
一种化合物的化学式为其中R1、R2、R3和R6相同或不同,每个都是氢原子或取代基;R4和R5中的一个是氢原子,另一个是代表公式的基团:—C(═X)—R7,其中X为N—O—R8或N—NH—R9,R8和R9相同或不同,每个都是氢原子或通过碳原子键合的基团;而R7是氢原子或取代基等。该化合物及其盐具有优异的IκB激酶抑制活性,并可用作预防或治疗糖尿病等药物。